Empowering Global Health: Rapid Diagnostics in Infectious Disease Detection from Development to Implementation

Upcoming Webinar on Tuesday, May 13, 2025 at 15:00 BST / 16:00 CEST / 10:00 EDT / 7:00 PDT 

What's the webinar about?

Explore the full journey of developing infectious disease lateral flow tests with experts from Lateral Dx and Medix Biochemica. Learn about critical stages in IVD development, strategies for optimizing antibody selection, and common pitfalls to avoid.

Discover the real-world impact of infectious disease diagnostics on global health and see performance data from Medix Biochemica antibodies in action.

Discussion points:  

• Key stages of IVD test development: concept to validation

• Challenges & pitfalls commonly experienced in assay development

• Considerations in antibody selection and workflow efficiencies

• Role of diagnostics in outbreak response

• Real-world importance of accessible testing

• Real and comparative data with Medix Biochemica antibodies

Key take aways: 

• IVD test development requires careful planning at every stage

• Antibody selection drives assay success

• Common issues can be avoided early

• Rapid diagnostics play a vital role in global health

• Real-world data helps guide better antibody choices

• Expert partnerships streamline development

Our speakers and host for the webinar

Richard Campbell

Founder & Managing Director, Lateral Dx

Richard Campbell is the Founder and Managing Director of Lateral Dx Ltd, specialists in lateral flow diagnostics. With over 20 years of industry experience, Richard leads a team dedicated to delivering high-quality, cost-effective solutions across lateral flow test development and manufacturing. Lateral Dx supports projects from early proof-of-principle through to large-scale production, with expertise spanning veterinary, clinical, environmental, infectious and drug testing applications. The company also offers rapid antibody pairing screening, providing quantitative results in as little as two weeks.

LinkedIn

Amy Moore

Global Product Manager, Medix Biochemica

Amy Moore is a Global Product Manager at Medix Biochemica, where she oversees the infectious disease portfolio. With a PhD in Microbiology from the University of New Hampshire, Amy brings a wealth of experience from the lab and quality assurance. Her deep passion for science, particularly infectious diseases, drives her commitment to delivering the best possible customer experience.

LinkedIn

Anthony Austin

Global Marketing Manager, Medix Biochemica

Anthony is the Global Marketing Manager for Medix Biochemica, starting in 2022. He enters this role after 15 years holding various science focused responsibilities in R&D, Manufacturing, Analytical and Product Management. Prior to Medix Biochemica, he worked in academic labs studying bone metabolism and genetic diseases affecting white blood cells and their ability to fight infections.

LinkedIn